{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medication+Management&page=7", "query": { "intervention": "Medication Management", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 6731, "total_pages": 674, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medication+Management&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medication+Management&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T03:37:51.861Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00364117", "title": "Remote Presence Timely Discharge Management", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Patient Discharge" ], "interventions": [ { "name": "Timely Discharge (Remote Presence Technology)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Hackensack Meridian Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2006-08", "completion_date": "2008-08", "has_results": false, "last_update_posted_date": "2013-05-07", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 1, "location_summary": "Hackensack, New Jersey", "locations": [ { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00364117" }, { "nct_id": "NCT05312255", "title": "Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Plasma Cell Myeloma", "Recurrent Plasma Cell Myeloma", "Refractory Plasma Cell Myeloma", "Smoldering Plasma Cell Myeloma" ], "interventions": [ { "name": "Behavioral Intervention", "type": "BEHAVIORAL" }, { "name": "Beta-Adrenergic Antagonist", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Resistance Training", "type": "OTHER" }, { "name": "Short-Term Fasting", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "DRUG", "OTHER" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 175, "start_date": "2022-06-28", "completion_date": "2027-06-28", "has_results": false, "last_update_posted_date": "2025-12-01", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05312255" }, { "nct_id": "NCT05915078", "title": "Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Otitis Media With Effusion", "Acute Otitis Media", "Otitis Media" ], "interventions": [ { "name": "Iontophoresis and tube placement", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Smith & Nephew, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Months to 17 Years" }, "enrollment_count": 200, "start_date": "2023-06-15", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2024-07-23", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 6, "location_summary": "Louisville, Kentucky • Cherry Hill, New Jersey • New Brunswick, New Jersey + 3 more", "locations": [ { "city": "Louisville", "state": "Kentucky" }, { "city": "Cherry Hill", "state": "New Jersey" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "New York", "state": "New York" }, { "city": "Ogden", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05915078" }, { "nct_id": "NCT03013985", "title": "Glargine U300 Hospital Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Glargine U300", "type": "DRUG" }, { "name": "Glargine U100", "type": "DRUG" }, { "name": "Glulisine Insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 247, "start_date": "2017-05-17", "completion_date": "2019-03-22", "has_results": true, "last_update_posted_date": "2020-05-07", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 4, "location_summary": "Atlanta, Georgia • Minneapolis, Minnesota • Cleveland, Ohio", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03013985" }, { "nct_id": "NCT03872843", "title": "Opioid Free Management After Ureteroscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Kidney Stone" ], "interventions": [ { "name": "Norco 5milligram-325milligram Tablet", "type": "DRUG" }, { "name": "Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2019-09-19", "completion_date": "2020-02-26", "has_results": true, "last_update_posted_date": "2021-03-11", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03872843" }, { "nct_id": "NCT05561725", "title": "Perioperative Steroid Dosing on the APR in AIS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Adolescent Idiopathic Scoliosis (AIS)" ], "interventions": [ { "name": "Dexamethasone postoperative", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "10 Years to 18 Years" }, "enrollment_count": 42, "start_date": "2023-01-03", "completion_date": "2026-04-01", "has_results": false, "last_update_posted_date": "2026-06-09", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05561725" }, { "nct_id": "NCT04229225", "title": "A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "UBX0101", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Unity Biotechnology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 35, "start_date": "2020-01-23", "completion_date": "2020-09-18", "has_results": false, "last_update_posted_date": "2020-10-19", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 7, "location_summary": "The Villages, Florida • Marietta, Georgia • St Louis, Missouri + 4 more", "locations": [ { "city": "The Villages", "state": "Florida" }, { "city": "Marietta", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Berlin", "state": "New Jersey" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04229225" }, { "nct_id": "NCT00645021", "title": "Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity", "Hepatic Insufficiency" ], "interventions": [ { "name": "CP-945,598", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2008-04", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2009-08-27", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 2, "location_summary": "Miami, Florida • Orlando, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00645021" }, { "nct_id": "NCT07291414", "title": "A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Carcinoma", "Colorectal Carcinoma", "Lung Carcinoma", "Malignant Solid Neoplasm", "Prostate Carcinoma" ], "interventions": [ { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Follow-Up", "type": "PROCEDURE" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2026-01-09", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2026-01-21", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07291414" }, { "nct_id": "NCT00061893", "title": "Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "celecoxib", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "vinblastine sulfate", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" }, { "name": "MESNA", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "50 Years", "sex": "ALL", "summary": "Up to 50 Years" }, "enrollment_count": 38, "start_date": "2004-04", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2019-02-15", "last_synced_at": "2026-10-20T03:37:51.861Z", "location_count": 87, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00061893" } ] }